American Society Of Haematology (ASH) Congress, 7th - 10th of December 2024, San Diego USA
American Congress of Obstetricians and Gynecologists (ACOG) Annual Meeting, May 17th - 19th 2024, San Francisco, California
Eli Lilly and Company announced results from the MONARCH 3 clinical trial, which will be presented in a late-breaking presentation during the 2023 San Antonio Breast Cancer Symposium (SABCS)
The Menarini Group will present additional data from the Phase III EMERALD study (NCT03778931) of elacestrant, an investigational oral SERD, during the upcoming San Antonio Breast Cancer Symposium (SABCS) being held from December 6-10
The Menarini Group and Radius Health, Inc. provided details on the elacestrant data from the EMERALD trial following the positive results presented at the San Antonio Breast Cancer Symposium (SABCS).
Lineage Cell Therapeutics, Inc. announced that it has entered into an exclusive option and license agreement with Neurgain Technologies, Inc. a medical device company that is commercializing technology developed by neurosurgeons at the University of California San Diego (“UC San Diego”).
The 5th of December sees the start of the San Antonio Breast Cancer Symposium 2017, in Texas, USA. This is the 40th anniversary of the scientific meeting organised by SABCS.
Survival for Women With Hormone Receptor - positive Advanced Breast Cancer improved with Ribociclib, reports unique study at 2017 San Antonio Breast Cancer Symposium
The 2018 American Academy of Dermatology Annual meeting will be held from 16th February – 20th February in San Diego, CA.